US Ends Prezista IP Suit Against Hetero Unit

Law360, New York (July 18, 2011, 7:28 PM EDT) -- The federal government on Monday resolved its patent infringement suit in New Jersey against India-based Hetero Drugs Ltd. Unit III over a generic version of HIV drug Prezista.

U.S. District Judge William H. Walls signed off on a joint stipulation that the parties had submitted, which was based on Hetero having amended its abbreviated new drug application to indicate that it was no longer seeking U.S. Food and Drug Administration approval of the generic product before the expiration of the patent-in-suit, according to court documents....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.